Although 'diseases of affluence', such as diabetes and cardiovascular disease, are increasing
in developing countries, infectious diseases still impose the greatest health burden. …

Background Few data exist on the comparative safety and immunogenicity of different
COVID-19 vaccines given as a third (booster) dose. To generate data to optimise selection of …

Background Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation
and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a …

An online survey was conducted to compare the safety, tolerability and reactogenicity of
available COVID-19 vaccines in different recipient groups. This survey was launched in …

COVID-19 pathogenesis is associated with an exaggerated immune response. However,
the specific cellular mediators and inflammatory components driving diverse clinical disease …

Viral hepatitis is a major global public health problem (Fig. 1) affecting hundreds of millions
of people and is associated with significant morbidity and mortality (Fig. 2). Five biologically …

Background Coronavirus disease 2019 (COVID-19) is associated with diffuse lung damage.
Corticosteroids may modulate immune-mediated lung injury and reducing progression to …

Background The monoclonal-antibody combination AZD7442 is composed of tixagevimab
and cilgavimab, two neutralizing antibodies against severe acute respiratory syndrome …

Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …

Objectives. To evaluate the risk of serious infections (SIs) in patients with RA treated with
anti-TNF therapy with emphasis on the risk across different ages. Methods. Using data from the …